Last updated on April 2017

3T MRI CIED Post-Approval Study

Brief description of study

The purpose of this study is to evaluate product performance of Magnetic Resonance (MR) Conditional Cardiac Implantable Electronic Devices (CIED) following 3 tesla (3T) MRI exposure. This will be achieved by evaluating the changes in pacing capture threshold (PCT) measurements following 3T MRI scan exposure. This study is required by FDA as a condition of approval of 3T MRI compatible labeling of applicable CIED systems. This study is conducted within Medtronic's post-market surveillance platform, the Product Surveillance Registry (PSR).

Clinical Study Identifier: NCT02969395


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Medtronic Product Surveillance Registry

Colorado Springs, CO United States
  Connect »

Medtronic Product Surveillance Registry

Saint Louis Park, MN United States
  Connect »